Nationwide Depo-Provera Brain Tumor Lawsuit Lawyer

Attorney Reviewed and Editorially Supervised

Reviewed by Jeffrey Glassman
Jeffrey Glassman Injury Lawyers
Nationwide injury claim intake for Depo-Provera meningioma cases
For a free consultation, call (617) 777-7777

Last reviewed: March 21, 2026

If you or someone you love was diagnosed with a brain tumor after using Depo-Provera, you may be searching for answers at the exact moment life feels most uncertain. Many women were prescribed this injectable contraceptive for convenience, privacy, and long-lasting pregnancy prevention. Very few expected that a medication given every three months could later become part of a serious neurological diagnosis involving headaches, vision changes, memory problems, seizures, ringing in the ears, balance issues, or surgery. When that happens, the legal questions are not abstract. They are deeply personal. You want to know what happened, whether the risks were known, whether stronger warnings should have been given, and what you can do now.

At Jeffrey Glassman Injury Lawyers, our Depo-Provera attorneys take these cases seriously and represent clients nationwide. A meningioma diagnosis can disrupt every part of daily life. Even when a meningioma is classified as noncancerous, it can still be life-altering because of where it grows and how it affects the brain, optic pathways, hearing, cognition, balance, and ability to work. Some women undergo brain surgery. Others face radiation, monitoring, permanent symptoms, or fear of recurrence. A nationwide Depo-Provera lawsuit is not just about a drug. It is about the human cost of living with a tumor that may never have developed, or may have been diagnosed earlier, if adequate warnings and precautions had been in place.

Keep up to date on Depo-Provera lawsuits here.

Depo-Provera is a brand name for depot medroxyprogesterone acetate, an injectable progestin-based medication used for contraception and in some settings for other medical purposes. Litigation now centers on whether long-term exposure to this medication is associated with an increased risk of meningioma, a tumor arising from the membranes surrounding the brain and spinal cord, and whether patients and prescribing professionals were adequately warned in the United States. Recent research and regulatory developments brought this issue into sharper focus. A 2024 BMJ study found that prolonged use of medroxyprogesterone acetate was associated with an increased risk of intracranial meningioma, and subsequent research in 2025 reported a higher relative risk, particularly with longer exposure. The current U.S. label now includes a meningioma warning, and official court records confirm the federal litigation has grown into a large multidistrict proceeding.

That matters because product-liability lawsuits often turn on what the manufacturer knew, what it should have known, what it communicated to regulators, what physicians and patients were told, and whether earlier warnings could have changed prescribing decisions. In a case like this, the central issues may include foreseeable risk, adequacy of warnings, timing of safety updates, pharmacovigilance, labeling strategy, and medical causation. Plaintiffs generally allege that they used Depo-Provera, later developed meningioma, and suffered damages that may include surgery, hospitalization, neurological injury, lost income, pain, emotional distress, and ongoing medical monitoring. Each claim is fact-specific, but the broad theory is that women deserved clear, timely risk information before their options narrowed to a tumor diagnosis.

A meningioma is often described as a usually benign tumor, but that phrase can be misleading in the real world. “Benign” does not mean harmless. A tumor inside the skull can compress important structures, trigger severe symptoms, and require invasive treatment. Depending on size and location, a meningioma can affect vision, hearing, smell, speech, coordination, memory, mood, concentration, and motor function. Some patients need a craniotomy. Some need stereotactic radiation. Some live with permanent deficits or anxiety over follow-up imaging for years. Others are told to wait and watch a lesion that still changes how they live every day. These are serious injuries, and any legal evaluation must treat them that way.

Nationwide claims have been centralized in federal court as MDL No. 3140, In re: Depo-Provera (Depot Medroxyprogesterone Acetate) Products Liability Litigation, in the Northern District of Florida. The Judicial Panel on Multidistrict Litigation created the MDL on February 7, 2025, for coordinated pretrial proceedings, and JPML statistics published in February 2026 show that the litigation has grown to more than 2,000 actions pending. That does not mean every case is automatically valid, nor that every claimant will recover. It does mean the litigation is significant, national in scope, and far beyond the stage of isolated filings. For injured women, MDL status usually signals that the courts recognize that common factual questions are substantial enough to be managed together.

An MDL is not a class action. Your claim remains your own. Your medical history, duration of Depo-Provera exposure, diagnosis date, tumor pathology, treatment history, age, prior risk factors, economic losses, and current impairments all matter. The right law firm should be able to explain that clearly. Good counsel should also be honest about timing, burden of proof, record gathering, and the possibility that settlement values can vary widely from case to case. A careful nationwide practice does not treat women like claim numbers. It builds the case one record, one timeline, and one medical fact at a time.

We keep you up-to-date on Depo-Provera litigation here.

In general, women may have a potential claim if they used Depo-Provera or depot medroxyprogesterone acetate injections and were later diagnosed with meningioma. The strongest cases often involve documented exposure over time, a confirmed imaging-based or pathology-based diagnosis, and meaningful damages tied to the tumor. That can include surgery, radiation, repeated MRI surveillance, visual or hearing changes, seizures, chronic headaches, cognitive symptoms, employment disruption, disability, out-of-pocket treatment costs, or profound life interference. A wrongful death claim may also exist in the rare case where complications proved fatal. Whether someone qualifies depends on medical records, timing, state law, and the specific facts of the case.

People often assume they cannot bring a claim because the prescription came from a doctor they trusted, because the drug helped them, or because the tumor is not labeled malignant. None of those facts automatically bars a case. Product-liability law can still apply when the underlying allegation is that the manufacturer failed to provide adequate warnings or safety information. The question is not whether your doctor intended harm. The question is whether the product’s risks were sufficiently disclosed for patients and physicians to make informed choices.

A strong Depo-Provera lawsuit usually begins with documentation. That includes pharmacy and prescribing records showing the use of the medication, dates of injections, if available, imaging reports such as MRI or CT, neurology and neurosurgery records, pathology records if surgery occurred, radiation oncology records, if applicable, and proof of how the diagnosis affected work and daily life. In many cases, your legal team will also want a chronological history showing when symptoms began, when the tumor was first identified, and how treatment unfolded. If you have records from multiple states or health systems, that is common in nationwide litigation and can be managed.

The best law firms in pharmaceutical injury litigation do more than order records. We build causation and damages in a disciplined way. We understand how to coordinate experts, preserve the story of the patient’s life before and after diagnosis, and present losses that are not fully captured by a bill ledger. The right representation should be organized, medically literate, responsive, and compassionate. You should not feel like you are being processed. You should feel heard.

Drug-injury cases are different from routine accident claims. They require command of scientific literature, regulatory history, mass-tort procedure, expert development, and the practical realities of federal litigation. They also require empathy. Women coming into these cases may still be in treatment. They may be frightened by the phrase “brain tumor.” They may be mothers, daughters, professionals, caregivers, students, or retirees whose routines changed overnight. A nationwide Depo-Provera page should reflect that reality, and the law firm behind it should too.

At Jeffrey Glassman Injury Lawyers, our approach is simple. We take serious injuries seriously. We believe people deserve straight answers, careful case screening, respectful communication, and representation that sees the full person, not just the diagnosis code. If you contact our firm about a Depo-Provera brain tumor claim, we can evaluate your history, explain the current status of the litigation, and help determine whether your situation appears consistent with the types of claims being pursued nationwide. That conversation should be clear, pressure-free, and grounded in the facts.

Read more in-depth FAQs about Depo-Provera brain tumor lawsuits.

If you were diagnosed with meningioma after receiving Depo-Provera injections, you do not need to sort through this alone. Our firm is prepared to review nationwide Depo-Provera brain tumor claims with care, urgency, and respect. We understand that this is not just a legal matter. It is a health crisis, a family disruption, and often a deeply emotional reckoning with what should have been disclosed sooner.

A strong case starts with a serious conversation. We can review your history, discuss whether your diagnosis and medication exposure are relevant to the litigation, and help you understand what steps come next. If your family has been living with surgery, radiation, neurological symptoms, lost work, or fear about the future, you deserve an advocate who recognizes the weight of that experience.

To speak with Jeffrey Glassman Injury Lawyers about a Nationwide Depo-Provera Brain Tumor Lawsuit Claim, call (617) 777-7777 for a free consultation. We are here to listen, to investigate, and to help you move forward with clarity.